Document And Entity Information
Document And Entity Information | Nov. 28, 2023 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Document Period End Date | Nov. 28, 2023 |
Entity Registrant Name | PROKIDNEY CORP. |
Entity Central Index Key | 0001850270 |
Entity Emerging Growth Company | true |
Entity File Number | 001-40560 |
Entity Incorporation, State or Country Code | E9 |
Entity Tax Identification Number | 98-1586514 |
Entity Address, Address Line One | 2000 Frontis Plaza Blvd. |
Entity Address, Address Line Two | Suite 250 |
Entity Address, City or Town | Winston-Salem |
Entity Address, State or Province | NC |
Entity Address, Postal Zip Code | 27103 |
City Area Code | 336 |
Local Phone Number | 999-7029 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Ex Transition Period | false |
Title of 12(b) Security | Class A ordinary shares, $0.0001 par value per share |
Trading Symbol | PROK |
Security Exchange Name | NASDAQ |
Amendment Description | This Current Report on Form 8-K/A (the “Amendment”) updates information originally provided under Item 5.02 in a Current Report on Form 8-K filed on November 30, 2023 (the “Original 8-K”), in which ProKidney Corp. (the “Company”) reported, among other things, the termination of Deepak Jain, Ph.D. as the Company’s Chief Operating Officer, effective November 28, 2023 (the “Separation Date”). This Amendment is being filed solely for the purpose to provide information regarding the Separation Agreement between Dr. Jain and the Company that was finalized subsequent to the filing of the Original 8-K. This Amendment does not otherwise modify or update any other disclosure contained in the Original 8-K, and should be read in conjunction with the Original 8-K. |